# To Evaluate the Safety of 'Shinbaro Capsule'in Patients With Osteoarthritis

> **NCT01604239** · PHASE4 · COMPLETED · sponsor: **Green Cross Corporation** · enrollment: 761 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** Shinbaro Capsule

## Key facts

- **NCT ID:** NCT01604239
- **Lead sponsor:** Green Cross Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 761 (ACTUAL)
- **Last updated:** 2013-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01604239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01604239, "To Evaluate the Safety of 'Shinbaro Capsule'in Patients With Osteoarthritis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01604239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*